SCHEMBL4463677

SCHEMBL4463677

COc1ccc(C)cc1C1(N)N=C(N)C=CN1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 1/20 0.42
ACHE P22303 1/20 0.39
KMT2A Q03164 5/20 0.34
MEN1 O00255 3/20 0.34
POLB P06746 2/20 0.34
TP53 P04637 2/20 0.34
MAPT P10636 2/20 0.34
MITF O75030 1/20 0.34
BLM P54132 1/20 0.34
LMNA P02545 4/20 0.33
BACE1 P56817 3/20 0.33
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MDM2 Q00987 1/20 0.33
HPGD P15428 1/20 0.32
ALOX5 P09917 1/20 0.32
EPHX2 P34913 1/20 0.32
MPI P34949 1/20 0.31
MMP14 P50281 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1171920 0.81 SMN1; SMN2 (0.43) ALDH1A1POLBLMNAKDM4ESMN1; SMN2
SCHEMBL1171998 0.79 CYP19A1 (0.35) ALDH1A1KMT2AMEN1TP53MAPT
SCHEMBL1171769 0.78 ALDH1A1 (0.41) ALDH1A1CYP3A4KMT2AMEN1POLB
SCHEMBL1171716 0.72 MAPT (0.37) ALDH1A1CYP3A4ACHEKMT2AMEN1
SCHEMBL1171710 0.71 HSP90AA1 (0.37) POLBMAPTBACE1SMN1; SMN2
SCHEMBL4458379 0.70 CYP3A4 (0.35) CYP3A4SMN1; SMN2
SCHEMBL1171878 0.69 ALDH1A1 (0.35) ALDH1A1POLBMAPTSMN1; SMN2HPGD
SCHEMBL12813223 0.66 HTT (0.38) ALDH1A1KMT2AMEN1BACE1KDM4E
SCHEMBL4459737 0.64 BACE1 (0.38) POLBBACE1EPHX2
SCHEMBL11042537 0.62 KMT2A (0.47) ALDH1A1CYP3A4ACHEKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO disclosed